Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Merck

Merck Stock Today: How A Bear Call Spread Can Return 10% In Less Than One Month

The maximum loss will occur if MRK closes above 115 on April 21.

Investors Business Daily

Does the future of medicine lie in space?

Earth’s gravity makes it harder to cultivate the proteins needed to study diseases and pathogens. And although the cost of space travel is high, private enterprise is stepping in

The Guardian - UK

Insurance Agencies Would Love to Know Who Blew Up Nord Stream

An era of gray zone warfare and sabotage creates tough financial questions.

Foreign Policy

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

Bangkok Post

Dow Jones Holds Above 32,000 As Index Bounce Fades; Financials Rocked Again As Regulators Shut Down SVB Financial

The Dow Jones climbed off lows Friday, but sellers regained control amid more broad-based selling in the financial sector.

Investors Business Daily

Could Merck's Next Keytruda-Like Franchise Generate $10 Billion In Sales?

Two of Merck's new drugs could generate north of $10 billion in peak sales, an analyst said Tuesday.

Investors Business Daily

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

The New Daily

Merck Livingston announces 15 new jobs and £2.6 million investment

Strategic partnership signed with Scottish Enterprise to develop novel quality control kit

Insider UK

The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks

Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.

Investors Business Daily

Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

Investors Business Daily

Dow Jones Battles Key Support As Indexes Trade Near Session Lows; Sellers Hit Chevron, Salesforce

The Dow Jones held up better than the Nasdaq composite midday Friday, helped by strong showings from Amgen, Merck and Coca-Cola.

Investors Business Daily

The cost of cybersecurity insurance is soaring–and state-backed attacks will be harder to cover. It’s time for companies to take threats more seriously

State-backed attacks are on the rise–and the insurance sector is increasingly excluding them from coverage.

Fortune

Top Fund Manager Found A Way To Make Money While Others Lose

Making money in an up market is easy. But showering investors with gains when stocks fall is far more challenging for the best mutual funds.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Merck Lands In Hot Water After 2023 Profit Guidance Widely Misses Forecasts

Merck's profit guidance for 2023 widely missed Wall Street's projections on Thursday, leading Merck stock to crumble despite a quarterly beat.

Investors Business Daily

Dow Jones Falls 275 Points After Jobless Claims; Meta Soars 20% On Strong Sales, $40 Billion Buyback

The Dow Jones fell Thursday after initial jobless claims. Meta stock soared 20% on a $40 billion stock buyback.

The Street

Merck Stock Slumps As 2023 Profit Outlook Clouds Q4 Earnings Beat

Merck said it sees 2023 sales in the region of $57.2 billion and $58.7 billion.

Tribune News Service

Merck COVID drug linked to new virus mutations, study says

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Tech Futures Jump As Meta Spikes After 'Gratifying' Fed Rally; Apple, Amazon, Google Earnings Next

Tech futures leapt as Meta spiked on its results, following the Fed's "gratifying" market rally. Apple, Amazon, Google earnings are next.

The Independent UK

Meet the German shepherd who was the richest dog in the world — and had a huge secret

“Gunther’s Millions”, a new Netflix documentary, investigates the story of Gunther, one in a long line of German Shepherds who had supposedly inherited a fortune from their late owner. Clémence Michallon reports

Daily Mirror

Who is Gunther? Inside hoax claims and secrets of world's richest dog in new Netflix doc

Netflix docuseries Gunther's Millions will explore the 'hoax' surrounding the world's richest dog Gunther and the man who cares for him, businessman Maurizio Mian

The Conversation

Cancer vaccine trials could start in the autumn – UK signs deal with BioNTech

The UK government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for developing, and which has been so successful at preventing serious illness and death from…

Investors Business Daily

Best Mutual Funds Report: Bulls In Hibernation In Bear Market

Tech names Nvidia remain absent as medical, oil, retail and machinery stocks top the list of new buys by the best mutual funds in bear market.

Investors Business Daily

IBD Stock Of The Day United Therapeutics Is Braving Competition, And Eyeing Two Entries

United Therapeutics is the IBD Stock Of The Day as competition heats up in its lung disease market. UTHR stock is eyeing two potential buy points.

Investors Business Daily

Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?

Merck is navigating a looming patent expiration for its blockbuster Keytruda. Now, Merck stock is trading at its highest point in decades.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations